AbDPP: Target-oriented antibody design with pretraining and prior biological structure knowledge.

Journal: Proteins
Published Date:

Abstract

Antibodies represent a crucial class of complex protein therapeutics and are essential in the treatment of a wide range of human diseases. Traditional antibody discovery methods, such as hybridoma and phage display technologies, suffer from limitations including inefficiency and a restricted exploration of the immense space of potential antibodies. To overcome these limitations, we propose a novel method for generating antibody sequences using deep learning algorithms called AbDPP (target-oriented antibody design with pretraining and prior biological knowledge). AbDPP integrates a pretrained model for antibodies with biological region information, enabling the effective use of vast antibody sequence data and intricate biological system understanding to generate sequences. To target specific antigens, AbDPP incorporates an antibody property evaluation model, which is further optimized based on evaluation results to generate more focused sequences. The efficacy of AbDPP was assessed through multiple experiments, evaluating its ability to generate amino acids, improve neutralization and binding, maintain sequence consistency, and improve sequence diversity. Results demonstrated that AbDPP outperformed other methods in terms of the performance and quality of generated sequences, showcasing its potential to enhance antibody design and screening efficiency. In summary, this study contributes to the field by offering an innovative deep learning-based method for antibody generation, addressing some limitations of traditional approaches, and underscoring the importance of integrating a specific antibody pretrained model and the biological properties of antibodies in generating novel sequences. The code and documentation underlying this article are freely available at https://github.com/zlfyj/AbDPP.

Authors

  • Chenglei Yu
    Department of Computer Science and Technology, Shanghai Normal University, Shanghai, China.
  • XiangTian Lin
    State Key Laboratory of Power Transmission Equipment Technology, School of Electrical Engineering, Chongqing University, Chongqing 400044, People's Republic of China.
  • Yuxuan Cheng
    Digital Innovation of AI, WuXi Biologics, Shanghai, China.
  • Jiahong Xu
    Digital Innovation of AI, WuXi Biologics, Shanghai, China.
  • Hao Wang
    Department of Cardiology, Second Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Yuyao Yan
    Department of Intelligent Science, Xi'an Jiaotong-Liverpool University, China.
  • Yanting Huang
    Digital Innovation of AI, WuXi Biologics, Shanghai, China.
  • Lanxuan Liu
    Digital Innovation of AI, WuXi Biologics, Shanghai, China.
  • Wei Zhao
    Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, Jiangsu Province, P. R. China. lxy@jiangnan.edu.cn zhuye@jiangnan.edu.cn.
  • Qin Zhao
    Department of Computer Science and Technology, Shanghai Normal University, Shanghai, China.
  • John Wang
    Department of Pathology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
  • Lei Zhang
    Division of Gastroenterology, Union Hospital, Tongji Medical College Medical College, Huazhong University of Science and Technology, Wuhan, China.